A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B

NCT07730567 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia
Diabete Type 2

Interventions

DRUG: Treatment A(AD-236A)
DRUG: Treatment B(AD-236B)
DRUG: Treatment C(AD-236A+AD-236B)

Sponsor

Addpharma Inc.